Last $33.40 MXN
Change Today -0.52 / -1.53%
Volume 1.2M
As of 1:20 PM 07/31/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Esteban Malpica Fomperosa

AgeTotal Calculated CompensationThis person is connected to 49 board members in 4 different organizations across 8 different industries.

See Board Relationships
64--

Background*

Mr. Esteban Malpica Fomperosa has been Managing Director and Partner of Praemia S.C. since April 2004. Mr. Fomperosa served as the Executive Vice President of Grupo Financiero Banamex Accival S.A. de C.V. from 1995 to 2001. Mr. Fomperosa serves as Statutory Director of Grupo Financiero Banamex-Accival S. A. de C. V. and is an Internal Member. From 1978 to 1995, he worked at Acciones y Valores de México, a securities broker, in various executive positions including its ...

Read Full Background

Corporate Headquarters*

Av. Jaime Balmes No. 8
Mexico city, Districto Federal Mexico 11510

Mexico

Phone: 52 55 5282 7300
Fax: 52 55 5282 7272

Board Members Memberships*

Director
Statutory Director
Former Director
Independent Director and Member of Audit & Corporate Practices Committee
Director
2001-N/A
Former Independent Director and Member of Finance & Plannning Committee
2003-2010
Former Director

Education*

MBA
University of Notre Dame
Bachelor's Degree 1971
Universidad Iberoamericana Ciudad de México

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KIMBERA:MM $33.32 MXN -0.60

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
$1.5M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Christopher A. Viehbacher Chief Executive Officer, Director and Member of Strategy Committee
Sanofi
€3.0M
Aijaz Tobaccowalla Managing Director, Additional Director and Member of Board Administrative Committee
Pfizer Limited
17.6M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KIMBERLY-CLARK DE MEXICO-A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.